[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-360499-105":59,"doc-detail-360499-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","impact-of-tlr4-and-myd88-genetic-variants-on-disease-progression-and-prognosis-in-laryngeal-squamous-cell-carcinoma","Impact of TLR4 and MYD88 Genetic Variants on Disease Progression and Prognosis in Laryngeal Squamous Cell Carcinoma","","Laryngeal cancer is an uncommon malignancy influenced by genetic predisposition that remains insufficiently clarified. This retrospective case–control study assessed whether single-nucleotide polymorphisms in innate immune signaling genes contribute to laryngeal squamous cell carcinoma risk, clinicopathological features, and patient survival. TLR4 polymorphisms and MYD88 polymorphisms were genotyped by real-time PCR from venous blood of 172 cases and 220 controls. MYD88 rs7744 related to tumor size, lymph node involvement, and poorer recurrence-free survival, whereas TLR4 rs7037225 CT carriers showed improved recurrence-free survival.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/impact-of-tlr4-and-myd88-genetic-variants-on-disease-progression-and-prognosis-in-laryngeal-squamous-cell-carcinoma/360499/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/impact-of-tlr4-and-myd88-genetic-variants-on-disease-progression-and-prognosis-in-laryngeal-squamous-cell-carcinoma/360499.png","ImageObject",300,407,{"name":92,"@type":93},"Grenda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the study goal regarding TLR4 and MYD88?","Question",{"text":113,"@type":114},"Evaluate associations of TLR4 and MYD88 genetic polymorphisms with LSCC risk, clinical/pathological characteristics, and survival outcomes.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were polymorphisms genotyped in the study?",{"text":118,"@type":114},"Genotyping was performed using real-time PCR from venous blood samples.",{"name":120,"@type":111,"acceptedAnswer":121},"Which variants were linked to survival or recurrence-free survival?",{"text":122,"@type":114},"MYD88 rs7744 was significantly associated with recurrence-free survival, while TLR4 rs7037225 CT genotype carriers showed significantly improved recurrence-free survival.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},360499,1790256779,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":26,"preview_page_count":19,"preview_urls":146},7971474921005,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Article  \nImpact of TLR4 and MYD88 Genetic Variants on Disease Progression and Prognosis in Laryngeal Squamous Cell Carcinoma  \nAkvil Mikulskien 1, Roberta Vadeikien 2,*, Aurelija Vegien 1, Rasa Ugenskien 2,3, Elona Juozaityte 4 and Evaldas Padervinskis 1  \nAcademic Editor: Amelia Casamassimi  \nReceived: 26 April 2026  \nRevised: 21 May 2026  \nAccepted: 22 May 2026  \nPublished: 25 May 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Otorhinolaryngology, Lithuanian University of Health Sciences, 50161 Kaunas, Lithuania; [akvile.mikulskiene@lsmu.lt](akvile.mikulskiene@lsmu.lt) (A.M.); [aurelija.vegiene@lsmu.lt](aurelija.vegiene@lsmu.lt) (A.V.); [evaldas.padervinskis@lsmu.lt](evaldas.padervinskis@lsmu.lt) (E.P.)  \n2 Oncology Research Laboratory, Institute of Oncology, Lithuanian University of Health Sciences,  \n50161 Kaunas, Lithuania; [rasa.ugenskiene@lsmu.lt](rasa.ugenskiene@lsmu.lt)  \n3 Department of Genetics and Molecular Medicine, Lithuanian University of Health Sciences,  \n50161 Kaunas, Lithuania  \n4 Institute of Oncology, Lithuanian University of Health Sciences, 50161 Kaunas, Lithuania; [elona.juozaityte@lsmu.lt](elona.juozaityte@lsmu.lt)  \n* Correspondence: [roberta.vadeikiene@lsmu.lt](roberta.vadeikiene@lsmu.lt)  \nAbstract  \nLaryngeal cancer is a relatively uncommon malignancy with predisposing genetic factors that remain unclear. Single-nucleotide polymorphisms (SNPs) in genes involved in innate immune signaling may contribute to the development and progression of laryngeal carcinoma. This study aimed to evaluate the association of TLR4 (rs7037225, rs11536889, rs7037117) and MYD88 (rs7744, rs6853) polymorphisms with the risk of laryngeal squamous cell carcinoma (LSCC), as well as its clinical and pathological characteristics and survival. A retrospective case–control study involving 172 LSCC patients and 220 healthy controls was conducted. Genotyping was performed using real-time PCR from venous blood samples. MYD88 rs7744 was significantly associated with tumor size and lymph node involvement. Survival analysis showed a significant association between rs7744 and recurrence-free survival (RFS), with the AG and GG genotypes linked to poorer outcomes. Conversely, carriers of the TLR4 rs7037225 CT genotype showed significantly improved RFS, with p ranging from 0.024 to 0.037 across models. Considering the significant roles of TLR4 and MYD88 in Toll-like receptor signaling, these findings may reflect the involvement of innate immune pathways in LSCC progression. In summary, MYD88 rs7744 was associated with clinicopathological features and RFS, while TLR4 rs7037225 appeared to have a potential protective effect on survival.  \nKeywords: SNP; TLR4; MYD88; laryngeal cancer  \n1. Introduction  \nLaryngeal cancer involves tumors of the supraglottic, glottic, and subglottic subsites. In 90–95% of cases, laryngeal cancer arises from the mucosal epithelium as squamous cell carcinoma (LSCC) . In contrast, non-squamous cell cancers, such as adenocarcinomas, neuroendocrine tumors, sarcomas, lymphomas, and minor salivary gland tumors, are rarely diagnosed. According to the latest WHO/IARC GLOBOCAN estimates for 2021, there were approximately 200,900 new cases of laryngeal cancer and 117,250 deaths globally, ranked among the top 20 cancers worldwide in both incidence and mortality [1] .  \nIn recent years, significant advances have been made in the treatment of LSCC patients; new biological and immunomodulatory therapies are improving relapse-free and overall survival. Unfortunately, early diagnosis remains problematic due to the lack of specific biomarkers that could help primary care physicians detect disease early and enable the most effective treatment. However, this is not the case; advanced-stage LSCC is diagnosed in the majority of patients, and overall sur","cbCaisoXSoWKvB8U","https://ap.wps.com/l/cbCaisoXSoWKvB8U","pdf",604542,24,"English","# Introduction\n## Genetic variants and innate immune signaling\n# Methods and study design\n## Case-control cohort and genotyping\n# Results\n## Associations with tumor features and survival","[{\"question\":\"What was the study goal regarding TLR4 and MYD88?\",\"answer\":\"Evaluate associations of TLR4 and MYD88 genetic polymorphisms with LSCC risk, clinical/pathological characteristics, and survival outcomes.\"},{\"question\":\"How were polymorphisms genotyped in the study?\",\"answer\":\"Genotyping was performed using real-time PCR from venous blood samples.\"},{\"question\":\"Which variants were linked to survival or recurrence-free survival?\",\"answer\":\"MYD88 rs7744 was significantly associated with recurrence-free survival, while TLR4 rs7037225 CT genotype carriers showed significantly improved recurrence-free survival.\"}]","Impact of TLR4 and MYD88 Genetic Variants on Disease Progression and Prognosis in Laryngeal Squamous Cell Carcinoma | PDF",1790140277,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/92ba389bd64fdcece90f9c10be4e1f67.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/96623dc4df99b3bc70223ad1c69cdf53.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4b57747c7aada1aa914ab343bdbb0002.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fa5fbd0fbcdea096bdfe1c4de97f26f6.webp",980,1385]